A Novel Transgenic Mouse for Gene-Targeting Within Cells That Express Corticotropin-Releasing Factor

Biological Psychiatry

Volumn 67, Issue 12, 2010, Pages 1212-1216

  Martin, Elizabeth I ^a   Ressler, Kerry J ^b   Jasnow, Aaron M ^c   Dabrowska, Joanna ^c   Hazra, Rimi ^c   Rainnie, Donald G ^c   Nemeroff, Charles B ^d   Owens, Michael J ^c  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; corticotropin releasing factor; Cre recombinase; lentiviral vector; promoter specificity; transgenic

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CRE RECOMBINASE; NEUROTRANSMITTER; INTEGRASE;

ANXIETY DISORDER; ARTICLE; ELECTROPHYSIOLOGY; GENE TARGETING; IN SITU HYBRIDIZATION; MOOD DISORDER; MOUSE; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; GENETICS; METABOLISM; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; GENE TARGETING; INTEGRASES; MICE; MICE, TRANSGENIC; NEURONS;

EID: 77952824291     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.01.026     Document Type: Article

References (24)

1. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
2. Melia K.R., and Duman R.S. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci U S A 88 (1991) 8382-8386
3. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?. Brain Res Brain Res Rev 15 (1990) 71-100
4. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur J Pharmacol 401 (2000) 39-46
5. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
6. Tache Y., and Brunnhuber S. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann N Y Acad Sci 1148 (2008) 29-41
7. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
8. Mitchell A.J. The role of corticotropin releasing factor in depressive illness: A critical review. Neurosci Biobehav Rev 22 (1998) 635-651
9. Risbrough V.B., and Stein M.B. Role of corticotropin releasing factor in anxiety disorders: A translational research perspective. Horm Behav 50 (2006) 550-561
10. Kapcala L.P., and Dicke J.A. Brain corticotropin-releasing hormone receptors on neurons and astrocytes. Brain Res 589 (1992) 143-148
11. Sawchenko P.E., and Swanson L.W. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44 (1985) 221-227
12. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., et al. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology 55 (1992) 451-459
13. Smialowska M., Wieroska J.M., and Wedzony K. A search for colocalization of mglula receptors with CRF or NPY in the rat brain amygdala. Folia Histochem Cytobiol 40 (2002) 153-154
14. Hisano S., Tsuruo Y., Katoh S., Daikoku S., Yanaihara N., and Shibasaki T. Intragranular colocalization of arginine vasopressin and methionine-enkephalin-octapeptide in CRF-axons in the rat median eminence. Cell Tissue Res 249 (1987) 497-507
15. Palkovits M. Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur J Pharmacol 405 (2000) 161-166
16. Chhatwal J.P., et al. Identification of cell-type-specific promoters within the brain using lentiviral vectors. Gene Ther 14 (2007) 575-583
17. Wilson T.J., and Kola I. The LoxP/CRE system and genome modification. Methods Mol Biol 158 (2001) 83-94
18. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2 (2001) 743-755
19. Tiscornia G., Singer O., Ikawa M., and Verma I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A 100 (2003) 1844-1848
20. Ressler K.J., Paschall G., Zhou X.L., and Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. J Neurosci 22 (2002) 7892-7902
21. Rainnie D.G., Mania I., Mascagni F., and McDonald A.J. Physiological and morphological characterization of parvalbumin-containing interneurons of the rat basolateral amygdala. J Comp Neurol 498 (2006) 142-161
22. McDonald A.J., Mascagni F., Mania I., and Rainnie D.G. Evidence for a perisomatic innervation of parvalbumin-containing interneurons by individual pyramidal cells in the basolateral amygdala. Brain Res 1035 (2005) 32-40
23. Rainnie D.G., Holmes K.H., and Shinnick-Gallagher P. Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala. J Neurosci 14 (1994) 7208-7220
24. Kurimoto K., Yabuta Y., Ohinata Y., Ono Y., Uno K.D., Yamada R.G., et al. An improved single-cell cDNA amplification method for efficient high-density oligonucleotide microarray analysis. Nucleic Acids Res 34 (2006) e42